Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Temazepam

Article Abstract:

Temazepam is administered in the form of tablets, capsules, and liquid and is used to treat insomnia by depressing the central nervous system. Its indications, contraindications, cautions, common side effects and interactions are described and it is suggested that before prescribing Temazepam the cause of insomnia should be established and any underlying factors should be treated.

Publisher: Macmillan Publishing Ltd.
Publication Name: Nursing Times
Subject: Health
ISSN: 0954-7762
Year: 2006
Complications and side effects, Drug therapy, Dosage and administration, Insomnia, Temazepam

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Motor neuron disease

Article Abstract:

Motor neuron disease (MND) is a group of progressive neurodegenerative diseases that predominantly affect the motor neurons of the spinal cord, cranial nerve nuclei and motor cortex and degeneration of these neurons leads to muscle wasting. The three main types of MND affecting different nerves are amyotrophic lateral sclerosis, progressive muscular atrophy and bulbar palsy.

Publisher: Macmillan Publishing Ltd.
Publication Name: Nursing Times
Subject: Health
ISSN: 0954-7762
Year: 2006
Care and treatment, Diagnosis, Risk factors, Motor neuron disease, Disease/Disorder overview

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United Kingdom
Similar abstracts:
  • Abstracts: The calling. Sargramostim for active Crohn's disease
  • Abstracts: Severe acute respiratory syndrome and dentistry: A retrospective view. Heart rate variability
  • Abstracts: Zollinger-Ellison syndrome. Furosemide
  • Abstracts: Modified directly observed therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.